| RS28371738 |
CYP2D6
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS28381817 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS28381825 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS28381827 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS28381848 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS28381875 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS28381877 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS28381903 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS28381920 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS28399499 |
CYP2B6
|
Drug Response |
drug response |
nevirapine response - Toxicity, CYP2B6-related disorder |
| RS28399504 |
CYP2C19
|
Drug Response |
drug response |
MEPHENYTOIN, POOR METABOLISM OF |
| RS28588594 |
CYP2D6
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS2884737 |
VKORC1
|
Drug Response |
drug response |
warfarin response - Dosage, warfarin response - Dosage |
| RS2888599 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS28929495 |
EGFR
|
Drug Response |
Likely pathogenic; drug response |
Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in |
| RS28933397 |
RYR1
|
Drug Response |
Likely pathogenic; drug response |
Malignant hyperthermia, susceptibility to |
| RS3064744 |
covers 10 genes, none of which curated to show dosage sensitivity
|
Drug Response |
Benign; drug response |
Gilbert syndrome, Crigler-Najjar syndrome |
| RS3213619 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS3214119 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS34097093 |
CYP2B6
|
Drug Response |
drug response |
Efavirenz response, Efavirenz response |
| RS34427887 |
IPCEF1;OPRM1
|
Drug Response |
drug response |
Tramadol response, Thymoma |
| RS34661811 |
UGT2B7
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS35478083 |
COMT
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS35481270 |
COMT
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS36079186 |
CYP2B6
|
Drug Response |
drug response |
Efavirenz response, Efavirenz response |
| RS36082074 |
COMT
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS368096241 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS368314788 |
COMT
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS368505753 |
CFTR
|
Drug Response |
Pathogenic; drug response |
Cystic fibrosis, ivacaftor response - Efficacy |
| RS370484811 |
CYP2D6
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS370803989 |
CYP2C19
|
Drug Response |
drug response |
CYP2C19: uncertain function, CYP2C19: uncertain function |
| RS370868117 |
OPRM1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS371202848 |
RMI1
|
Drug Response |
drug response |
Olaparib response, Olaparib response |
| RS371424910 |
CYP2B6
|
Drug Response |
drug response |
Efavirenz response, Efavirenz response |
| RS372708040 |
CYP2D6
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS373000587 |
CYP2D6
|
Drug Response |
drug response |
— |
| RS373107309 |
UGT2B7
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS373236080 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS373489637 |
CYP2B6
|
Drug Response |
drug response |
Efavirenz response, Efavirenz response |
| RS373611092 |
COMT
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS373789868 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS373954369 |
UGT2B7
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS3745274 |
CYP2B6
|
Drug Response |
drug response |
Efavirenz response, efavirenz response - Metabolism/PK |
| RS375135093 |
CYP2D6
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS375413467 |
CYP2D6
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS375781227 |
CYP2C19
|
Drug Response |
drug response |
CYP2C19: decreased function, CYP2C19: decreased function |
| RS377260637 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS377623963 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS377704466 |
OPRM1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS37973 |
GLCCI1
|
Drug Response |
drug response |
Glucocorticoid therapy, response to |
| RS3812718 |
SCN1A
|
Drug Response |
drug response |
Febrile seizures, familial |
| RS3842 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS3892097 |
CYP2D6
|
Drug Response |
Likely benign; drug response; other |
Debrisoquine, poor metabolism of |
| RS397508288 |
CFTR
|
Drug Response |
drug response |
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS397508442 |
CFTR
|
Drug Response |
Pathogenic; drug response |
Cystic fibrosis, ivacaftor response - Efficacy |
| RS397508513 |
CFTR
|
Drug Response |
drug response |
Cystic fibrosis, ivacaftor response - Efficacy |
| RS397509368 |
EGFR
|
Drug Response |
drug response |
Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in |
| RS397509427 |
VKORC1
|
Drug Response |
drug response |
Warfarin response, Warfarin response |
| RS397517085 |
EGFR
|
Drug Response |
drug response |
Tyrosine kinase inhibitor response, Lung carcinoma |
| RS397517109 |
EGFR
|
Drug Response |
drug response |
Non-small cell lung carcinoma, Tyrosine kinase inhibitor response |
| RS397517115 |
EGFR
|
Drug Response |
drug response |
Tyrosine kinase inhibitor response, Neoplasm |
| RS405509 |
APOE
|
Drug Response |
drug response |
Coronary artery disease, severe |
| RS41291556 |
CYP2C19
|
Drug Response |
drug response |
CYP2C19: no function, CYP2C19: no function |
| RS4148323 |
covers 10 genes, none of which curated to show dosage sensitivity
|
Drug Response |
Conflicting classifications of pathogenicity; drug response |
Gilbert syndrome, BILIRUBIN |
| RS4148727 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS4149056 |
SLCO1B1
|
Drug Response |
drug response |
Rotor syndrome, simvastatin acid response - Metabolism/PK |
| RS4244285 |
CYP2C19
|
Drug Response |
drug response |
Acute coronary syndrome, Acute coronary syndrome |
| RS4292394 |
UGT2B7
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS4337789 |
UGT2B7
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS439401 |
APOE
|
Drug Response |
drug response |
Warfarin response, Warfarin response |
| RS45511401 |
ABCC1
|
Drug Response |
drug response |
Atorvastatin response, Atorvastatin response |
| RS4629571 |
-
|
Drug Response |
drug response |
Statins, attenuated cholesterol lowering by |
| RS4646437 |
CYP3A4
|
Drug Response |
drug response |
tacrolimus response - Metabolism/PK, tacrolimus response - Metabolism/PK |
| RS4673993 |
ATIC
|
Drug Response |
drug response |
methotrexate response - Efficacy, methotrexate response - Efficacy |
| RS4720470 |
NPC1L1
|
Drug Response |
drug response |
Statins, attenuated cholesterol lowering by |
| RS479292 |
CASC6
|
Drug Response |
drug response |
Letrozole response, Letrozole response |
| RS483352805 |
EGFR
|
Drug Response |
drug response |
Squamous cell carcinoma of the head and neck, Squamous cell carcinoma of the head and neck |
| RS483352807 |
EGFR
|
Drug Response |
drug response |
Squamous cell carcinoma of the head and neck, Squamous cell carcinoma of the head and neck |
| RS483352808 |
EGFR
|
Drug Response |
drug response |
Squamous cell carcinoma of the head and neck, Squamous cell carcinoma of the head and neck |
| RS4961 |
ADD1
|
Drug Response |
drug response |
Hypertension, salt-sensitive essential |
| RS497332 |
OPRM1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS4986893 |
CYP2C19
|
Drug Response |
drug response |
MEPHENYTOIN, POOR METABOLISM OF |
| RS5030655 |
CYP2D6
|
Drug Response |
Benign/Likely benign; drug response; other |
Debrisoquine, poor metabolism of |
| RS527753359 |
CYP2D6
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS528747108 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS530422334 |
CYP2D6
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS532094830 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS536957156 |
OPRM1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS538707090 |
CYP2D6
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS539878014 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS540076362 |
CYP2D6
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS540825 |
OPRM1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS541561684 |
COMT
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS542615961 |
OPRM1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS544846648 |
COMT
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS545334485 |
CYP2D6
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS546524303 |
OPRM1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS547093769 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS548235125 |
COMT
|
Drug Response |
drug response |
Tramadol response, Tramadol response |
| RS549753290 |
ABCB1
|
Drug Response |
drug response |
Tramadol response, Tramadol response |